Clinical Data and 99mTc-MIBI Uptake in 29 Patients with ICH
| Patient no. | Age (y) | Sex | Location | Visual analysis (early images) | ER | DR | RI | Diagnosis |
|---|---|---|---|---|---|---|---|---|
| 1 | 52 | M | L occipital | Positive | 3.95 | 1.5 | 0.38 | Lung cancer metastasis |
| 2 | 72 | F | L frontal | Positive | 2.13 | 1 | 0.46 | Malignant cutaneous melanoma metastasis |
| 3 | 60 | F | L occipital | Positive | 3.3 | 1.9 | 0.57 | Hypernephroma metastasis |
| 4 | 80 | M | R frontal | Positive | 3.12 | 3.19 | 1.02 | Colon cancer metastasis |
| 5 | 63 | F | R frontal | Positive | 2 | 1.6 | 0.8 | Malignant cutaneous melanoma metastasis |
| 6 | 50 | M | R occipital | Positive | 5.5 | 3.3 | 0.6 | Lung cancer metastasis |
| 7 | 63 | M | R frontotemporal | Positive | 2 | 2 | 1 | Glioblastoma multiforme |
| 8 | 52 | M | R frontal | Positive | 2.1 | 2 | 0.95 | Glioblastoma multiforme |
| 9 | 51 | M | L parietal | Positive | 3.4 | 2 | 0.6 | Anaplastic ependymoma |
| 10 | 63 | F | L parietal | Positive | 2.13 | 2.2 | 1.03 | Angioblastic meningioma |
| 11 | 28 | F | Midbrain, R superior cerebral pedicle and R thalamus | Negative | 1.05 | 1 | 0.95 | Vascular degenerative disease |
| 12 | 27 | F | L parietal | Negative | 1.08 | 0.98 | 0.9 | Vascular degenerative disease |
| 13 | 56 | M | R temporoparietal | Negative | 0.96 | 0.9 | 0.93 | Vascular degenerative disease |
| 14 | 40 | M | R parietal | Negative | 1.02 | 0.97 | 0.95 | Vascular degenerative disease |
| 15 | 63 | F | L insular | Negative | 0.97 | 0.98 | 1.01 | Vascular degenerative disease |
| 16 | 36 | M | R thalamus | Negative | 1 | 1.01 | 1.01 | Vascular degenerative disease |
| 17 | 50 | F | L frontal | Negative | 0.95 | 1.02 | 1.07 | Vascular degenerative disease |
| 18 | 47 | F | L frontal | Negative | 0.91 | 0.98 | 1.07 | Vascular degenerative disease |
| 19 | 38 | M | R frontal | Negative | 1.08 | 1.08 | 1 | Vascular degenerative disease |
| 20 | 60 | M | L occipital | Negative | 1 | 1.03 | 1.03 | Vascular degenerative disease |
| 21 | 76 | F | L parietal | Negative | 1.04 | 1 | 0.96 | Vascular degenerative disease |
| 22 | 78 | M | R frontal | Negative | 1.1 | 1 | 0.9 | Vascular degenerative disease |
| 23 | 72 | F | L temporal | Negative | 1.06 | 1.09 | 1.02 | Vascular degenerative disease |
| 24 | 51 | M | R cerebellar hemisphere | Negative | 1 | 1.06 | 1.06 | Vascular degenerative disease |
| 25 | 62 | F | R occipital | Negative | 1.12 | 1.03 | 0.92 | Vascular degenerative disease |
| 26 | 48 | F | L parietal | Negative | 1.2 | 1.18 | 0.98 | Sinus rectus thrombosis |
| 27 | 52 | F | R insular | Negative | 1.3 | 1 | 0.77 | Thrombosed middle cerebral artery giant aneurysm |
| 28 | 58 | M | R occipital, paratrigonal | Negative | 0.89 | 0.92 | 1.03 | Cavernous angioma |
| 29 | 42 | F | L temporal | Negative | 0.9 | 0.95 | 1.05 | Cavernous angioma |